+34 672643706 editor@vitascientia.net
ISSN: 3101-173X Vita Scientia (Madrid)
Vita Scientia – Volume 2, Issue 1 (January 2026)
Journal Cover

Vita Scientia – Volume 1, Issue 2 (January 2026)

(September 2025)
Download Full Issue (PDF)

📢 Published on: 31 January 2026

Short Commentary

Cover image
For decades, Artificial Intelligence (AI) was cast as a background tool—an efficient processor of data, a passive observer assisting scientists in making sense of complexity [1]. Sustainability, by contrast, was championed as a fundamentally human pursuit, tied to ethical choices and political will. Yet this dichotomy is now dissolving. Emerging applications suggest that AI is not simply supporting sustainability but coevolving with it, offering dynamic, context-sensitive strategies for navigating the environmental and biological crises of our time.
Authors: ,
Published on:

Review Articles

Cover image
Paracoccus denitrificans is a metabolically adaptable prokaryote equipped with diverse oxidoreductase enzymes that enable persistence across soil, marine, and industrial environments. This study reviews key reductase enzyme families, including flavin, iron, quinone, and chromate/chromate-related reductases, emphasizing their biochemical roles and biotechnological potential. Flavin reductases catalyze coupled electron transfer, reducing both NAD(P)H to its active nicotinamide form and FAD to FADH₂.
Authors: ,
Published on:
Cover image
Advances in next-generation sequencing (NGS) technologies have revolutionized our knowledge of the transcriptome, leading to the discovery of multiple classes of non-coding RNAs (ncRNAs) across all kingdoms of life. While coding RNA mainly serves as a template for synthesis of protein, the ncRNAs carry out diverse regulatory functions and modulate gene expression at multiple stages mainly at epigenetic, transcriptional, post-transcriptional, and translational levels.
Authors: , , ,
Published on:
Cover image
Cancer continues to pose a significant global health challenge, prompting continuous research and innovation in therapeutic modalities. Among the evolving methods and approaches, therapies derived from peptides have emerged as an upcoming frontier, within the bounds of anticancer treatments. Peptides play a crucial role in pathophysiology, diagnosis, and treatment of hematologic malignancies. These short amino acid chains influence tumour growth, immune response, and cellular signaling in leukemia, lymphoma, and multiple myeloma.
Authors: ,
Published on: